• $199.3M
    Market Cap
  • -76.77%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-9.3M
+28.82%
-7.3M
-4.86%
-7.6M
+20.51%
-6.3M
+150.66%
Depreciation and Amortization Expense
N/A
N/A
735
-42.76%
1,284
-27.91%
1,781
+26.94%
Total Operating Expenses
19.8M
+29.08%
15.4M
-6.18%
16.4M
+9.84%
14.9M
+92.92%
Operating Profit
-19.8M
+29.08%
-15.4M
-6.18%
-16.4M
+9.84%
-14.9M
+92.92%
Interest Income
138,018
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
138,018
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
138,018
-59.85%
343,724
-64.01%
955,003
+62.39%
588,108
+3,218.52%
Income before Taxes
-19.8M
+29.08%
-15.4M
-6.18%
-16.4M
+9.84%
-14.9M
+92.92%
Income Taxes
1,716
+0.94%
1,700
-30.61%
2,450
+8,066.67%
30
-98.18%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-15.0M
-2.60%
-15.4M
+7.68%
-14.3M
+85.74%
Net Income from Continuing Operations Applicable to Common
-20.8M
+38.78%
-15.0M
-2.60%
-15.4M
+7.68%
-14.3M
+85.74%
Basic EPS and Net Income
-21.58
+1,240.37%
-1.61
-12.02%
-1.83
+5.78%
-1.73
-8.47%
Diluted EPS and Net Income
-21.58
+1,240.37%
-1.61
-12.02%
-1.83
+5.78%
-1.73
-8.47%
Basic Weighted Average Shares
966,124
-89.67%
9.4M
+11.36%
8.4M
+1.68%
8.3M
+101.98%
Diluted Weighted Average Shares
966,124
-89.67%
9.4M
+11.36%
8.4M
+1.68%
8.3M
+101.98%
Balance Sheet
Cash and Cash Equivalents
8.5M
+47.02%
5.8M
-56.69%
13.4M
+38.80%
9.6M
-75.40%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
16.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
8.5M
+47.02%
5.8M
-56.69%
13.4M
-49.45%
26.4M
-32.45%
Total Current Assets
9.3M
+40.67%
6.6M
-52.71%
14.0M
-48.63%
27.2M
-32.54%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
735
-63.60%
2,019
-46.87%
Total Long-Term Assets
100,000
-86.12%
720,426
-22.42%
928,669
+13.31%
819,564
+332.80%
Total Assets
9.3M
+26.86%
7.3M
-50.83%
14.9M
-46.82%
28.1M
-30.84%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.2M
+81.46%
3.4M
+22.34%
2.8M
-19.20%
3.4M
-25.43%
Total Long-Term Debt
5.7M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
84,164
+14.75%
73,348
-8.88%
80,494
+10.47%
Total Liabilities
6.2M
+81.46%
3.4M
+19.19%
2.8M
-17.07%
3.4M
-26.59%
Retained Earnings
-81.3M
+34.50%
-60.4M
+33.08%
-45.4M
+51.42%
-30.0M
+91.40%
Total Stockholders Equity
3.2M
-20.11%
3.9M
-67.33%
12.1M
-50.97%
24.6M
-31.39%
Total Shares Outstanding
2.2M
-81.96%
12.0M
+43.00%
8.4M
0.00%
8.4M
+1.72%
Cash Flow
Cash from Operating Activities
-14.8M
+20.29%
-12.3M
-8.07%
-13.4M
+2.50%
-13.1M
+15.83%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
17.1M
+204.34%
-16.4M
-3,768.83%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
17.5M
+269.51%
4.7M
N/A
N/A
N/A
N/A
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
-134.95%
+88.07%
-71.76%
+71.94%
-41.73%
N/A
Return on Equity
N/A
N/A
-187.52%
+123.15%
-84.04%
+77.57%
-47.32%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.51
-22.48%
1.95
-61.35%
5.05
-36.42%
7.94
N/A
Cash Ratio
1.38
-18.98%
1.71
-64.60%
4.82
+71.79%
2.80
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow